| 标题 |
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Kelly G. Paulson; Sally C. M. Lau; Myung‐Ju Ahn; Mor Moskovitz; Michael Pogorzelski; et al 出版日期:2025-09-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)